1.
Luo J, Yuan M, Li S, et al. Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment. Rev. Inst. Med. Trop. São Paulo. 2024;66:e27. doi:10.1590/